Transcriptional activators differ in their abilities to control alternative splicing
about
sameAs
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancerThe WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivoDeep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAsEpigenetics in alternative pre-mRNA splicingFAST DB: a website resource for the study of the expression regulation of human gene products.Mutual relationships between transcription and pre-mRNA processing in the synthesis of mRNACoupling pre-mRNA processing to transcription on the RNA factory assembly lineChromatin, DNA structure and alternative splicingTranscriptional activators control splicing and 3'-end cleavage levelsTranscriptional activity of androgen receptor is modulated by two RNA splicing factors, PSF and p54nrb.Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasionThe C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing.Linking splicing to Pol II transcription stabilizes pre-mRNAs and influences splicing patternsThe "alternative" choice of constitutive exons throughout evolution.HIFs enhance the transcriptional activation and splicing of adrenomedullin.Complex exon-intron marking by histone modifications is not determined solely by nucleosome distribution.Evolution at protein ends: major contribution of alternative transcription initiation and termination to the transcriptome and proteome diversity in mammals.First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal.Histone deacetylase activity modulates alternative splicing.Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation.Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo.Regulation of alternative splicing by histone modifications.Threonine-4 of the budding yeast RNAP II CTD couples transcription with Htz1-mediated chromatin remodeling.Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns.Vezf1 protein binding sites genome-wide are associated with pausing of elongating RNA polymerase II.Diversity in TAF proteomics: consequences for cellular differentiation and migration.RNA polymerase II CTD modifications: how many tales from a single tail.Pre-mRNA splicing is a determinant of nucleosome organizationFunctional coupling of RNAP II transcription to spliceosome assemblyTranscriptome-wide modulation of splicing by the exon junction complex.Modeling exon expression using histone modifications.Pre-mRNA splicing is a determinant of histone H3K36 methylationNFAT1 and NFAT3 cooperate with HDAC4 during regulation of alternative splicing of PMCA isoforms in PC12 cellsHu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner.Multiple links between transcription and splicing.Mechanisms of the androgen receptor splicing in prostate cancer cells.Co-transcriptional regulation of alternative pre-mRNA splicingLong range chromatin organization: a new layer in splicing regulation?
P2860
Q24318348-7B8AFCD6-649D-463D-86AF-4F07C953D454Q24561427-A8B43D2C-BC34-4070-AD1D-4CD0A1AFE421Q24609086-CA2A1A5C-78CF-480B-A0EB-C75A604E473BQ24625879-AED5091D-D8DF-42E9-BE4B-5DA33AEE9C7FQ24815689-90989811-31AF-41C1-B8C9-7F8D16215AFAQ26851218-B926201F-F86D-4CC4-88B0-C641F9D9CECDQ27024720-730A2F33-179A-4DA1-8AB4-AEF11BBA1943Q28081880-D7C61313-FC54-4534-B516-C876501C278AQ28486904-83B8525F-30B1-462C-9405-DD08577E32D1Q30444291-6C9EFF25-976D-4F50-B0C6-BB63F48402EDQ30553128-6943D67B-19AF-40C3-A5BB-FBCC2BE26293Q30557271-4ECA2618-AA86-4B8D-8AB0-23CAF247DEB9Q33241167-D744C593-8B9F-46E4-A13D-00C6BFDD0427Q33306111-C5802690-6679-473C-B1A8-25197721F46BQ33611004-44C76B21-25D0-4CD1-ADD6-B9076D25C69BQ33680184-25BAA663-5186-4931-B0F9-538190055872Q33791162-49C41159-2162-4D90-8AD1-5A23EE6AC0DCQ33799119-76279B7A-F962-44A9-AB74-5C8D5E9A6E0AQ33818140-FE758305-7838-4898-BBAB-7E770CFE9911Q33832763-EC0CD9EB-9C5C-42A0-B4C7-FDCD3B342780Q33859710-D04467C3-BF64-4173-A5AD-4B752E01A95DQ33925205-72F70158-9D0E-4ABF-ACE5-B7B374BF58F6Q34035543-A58CC479-8DCB-4AEF-84DF-BF00E8EECF91Q34082953-CC303828-C55C-49D6-8559-F6027B570D52Q34124490-7C0D662B-2E52-4B57-B442-0D6655657CF9Q34222289-194AE4FF-82B0-4D3E-A1DC-6619243DE248Q34252430-0B30069D-86E5-43B4-9F27-12B5F807CDB3Q34358974-B853070A-7270-4EDE-954E-29F264D607B9Q34377487-A8342DC2-6AE1-4EE6-9558-7A25F8BDDF5CQ34551455-9C846811-C530-4494-871C-A3D09F549087Q34650438-5FD0BA72-BEAA-4852-903A-742DA81126CFQ34720781-69FA592C-C57E-4F39-8C55-416E431840C9Q34794970-82B5FDD2-23F9-4D24-8ED9-240F88DC1382Q35170883-04CF3E48-726C-4206-973A-F7DFA9C448A6Q35182763-58501B51-D101-4F24-83FC-CA6C8D8A36D6Q35202794-04E477A8-188B-41EB-8C59-D3996DFEEB93Q35895223-A9349563-8EF8-4DC3-99E2-83A8CA622D14Q36005683-AC1FEA7B-D658-4C75-8684-B798F541A1E9Q36019901-DF64F605-1766-4F52-952C-BBE7A6545DE5Q36072603-3F72142A-7C2F-4227-8561-732EEA25E2BB
P2860
Transcriptional activators differ in their abilities to control alternative splicing
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Transcriptional activators differ in their abilities to control alternative splicing
@ast
Transcriptional activators differ in their abilities to control alternative splicing
@en
Transcriptional activators differ in their abilities to control alternative splicing
@nl
type
label
Transcriptional activators differ in their abilities to control alternative splicing
@ast
Transcriptional activators differ in their abilities to control alternative splicing
@en
Transcriptional activators differ in their abilities to control alternative splicing
@nl
prefLabel
Transcriptional activators differ in their abilities to control alternative splicing
@ast
Transcriptional activators differ in their abilities to control alternative splicing
@en
Transcriptional activators differ in their abilities to control alternative splicing
@nl
P2093
P2860
P3181
P356
P1476
Transcriptional activators differ in their abilities to control alternative splicing
@en
P2093
David Bentley
Guadalupe Nogues
Paula Cramer
Sebastian Kadener
P2860
P304
P3181
P356
10.1074/JBC.M208418200
P407
P577
2002-11-08T00:00:00Z